Central Vertigo and Peripheral Vertigo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Retrospective cohort: Patients who presented with acute or subacute vertigo or dizziness as the primary chief complaint to the Emergency Department or the Emergency Neurology Department of Xuzhou First People's Hospital, or to the Emergency Department of Henan Shenhuo General Hospital, between January 2024 and December 2025; were subsequently hospitalized; and were definitively diagnosed with central or peripheral vertigo based on clinical evaluation and auxiliary examinations. 3.complaint to the Emergency Department or the Emergency Neurology Department of Xuzhou First People's Hospital between May 2026 and June 2026; were subsequently hospitalized; and were definitively diagnosed with central or peripheral vertigo based on clinical evaluation and auxiliary examinations.
Exclusion criteria
Exclusion criteria: 1. Vertigo directly ascribable to well-defined external causes, such as physical trauma, acute intoxication, drug poisoning, or severe systemic infection. 2.Dizziness clearly attributable to psychogenic factors (e.g., panic attack, generalized anxiety disorder) that have been determined to be the sole cause of the symptoms. 3.Undifferentiated dizziness of unknown etiology that remains unclassifiable as central or peripheral vertigo even after a comprehensive clinical evaluation. 4. Cases concurrently exhibiting features of both central and peripheral vertigo, precluding unambiguous classification into a single category. 5. Diagnostic uncertainty resulting from failure to complete definitive confirmatory neuroimaging due to practical constraints, such as contraindications to MRI (e.g., presence of metal implants).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| age;sex;nature of symptom;duration of symptoms;associated symptoms;hypertension;diabetes mellitus;cerebral infarction;cerebral hemorrhage;coronary heart disease;atrial fibrillation;surgery;smoking;alcohol;allergy;allergy;High-sensitivity C-reactive protein;plasma D-dimer;routine hemostasis and coagulation tests;blood biochemistry;cardiac enzymes; | — |
Countries
China
Contacts
Xuzhou No 1 People’s Hospital